PFIZER INC. (LON:PFZ) Files An 8-K Other Events
Item8.01 Other Events
On March17, 2017, Pfizer Inc. (the Company) completed the
previously announced public offering of $1,065,000,000 aggregate
principal amount of 4.20% Notes due 2047 (the Notes), to the
subscription agreement dated February24, 2017 among the Company,
BNP Paribas, Taipei Branch and Deutsche Bank AG, Taipei Branch,
as managers.
The offering of the Notes was made to the Companys shelf
registration statement on Form S-3 (Registration No.333-202430)
filed with the Securities and Exchange Commission on March2,
2015.
The Notes were issued to an indenture, dated as of January30,
2001, between the Company and The Bank of New York Mellon
(formerly known as The Bank of New York), as successor to
JPMorgan Chase Bank (formerly known as The Chase Manhattan Bank),
as trustee, as supplemented by the eighth supplemental indenture,
dated as of March17, 2017, among the Company and The Bank of New
York Mellon, as trustee and The Bank of New York Mellon, London
Branch, as paying agent (the Eighth Supplemental Indenture).
The Eighth Supplemental Indenture is filed herewith as Exhibit
4.2 to this Form 8-K and is incorporated herein by reference.
In addition, in connection with the offering of the Notes, the
Company is filing a legal opinion regarding the validity of the
Notes, filed herewith as Exhibit 5.1 to this Form 8-K and is
incorporated herein by reference.
Item9.01 Financial Statements and Exhibits
(d)Exhibits
|
ExhibitNo. |
Exhibit Description |
|
| 4.1 |
Indenture, dated as of January30, 2001, between Pfizer Inc. and The Bank of New York Mellon (formerly known as The Bank of New York), as successor to JPMorgan Chase Bank (formerly known as The Chase Manhattan Bank), as trustee (incorporated by reference from the Companys Current Report on Form 8-K filed on January30, 2001) |
|
| 4.2 |
Eighth Supplemental Indenture, dated as of March17, 2017, among Pfizer Inc., The Bank of New York Mellon, as trustee and The Bank of New York Mellon, London Branch, as paying agent |
|
| 4.3 | Form of 4.20% Notes due 2047 (included in Exhibit 4.2) |
|
ExhibitNo. |
Exhibit Description |
|
| 5.1 |
Opinion of Margaret M. Madden, Senior Vice President and Corporate Secretary, Chief Governance Counsel of the Company |
|
| 23.1 |
Consent of Margaret M. Madden, Senior Vice President and Corporate Secretary, Chief Governance Counsel of the Company (included in Exhibit 5.1) |
PFIZER INC. (LON:PFZ) Recent Trading Information
PFIZER INC. (LON:PFZ) closed its last trading session up +0.10 at 34.41 with 0 shares trading hands.
